U.S. Army’s Hemp Research, Mississippi’s Medical Cannabis Program, and Japan’s Synthetic Cannabinoid Gray Market
Veriheal
JULY 8, 2022
At the program’s launch, those with cancer, HIV/AIDS, sickle cell, terminal illnesses, or any medical conditions which cause seizures, chronic pain, and other ailments will be covered under the list of applicable conditions. If approved, patients will be able to purchase medical cannabis for 12 months before they have to renew.
Let's personalize your content